Literature DB >> 25261240

GPx2 suppression of H2O2 stress links the formation of differentiated tumor mass to metastatic capacity in colorectal cancer.

Benjamin L Emmink1, Jamila Laoukili1, Anna P Kipp2, Jan Koster3, Klaas M Govaert1, Szabolcs Fatrai1, Andre Verheem1, Ernst J A Steller1, Regina Brigelius-Flohé2, Connie R Jimenez4, Inne H M Borel Rinkes1, Onno Kranenburg5.   

Abstract

Colorectal tumorigenesis is accompanied by the generation of oxidative stress, but how this controls tumor development is poorly understood. Here, we studied how the H2O2-reducing enzyme glutathione peroxidase 2 (GPx2) regulates H2O2 stress and differentiation in patient-derived "colonosphere" cultures. GPx2 silencing caused accumulation of radical oxygen species, sensitization to H2O2-induced apoptosis, and strongly reduced clone- and metastasis-forming capacity. Neutralization of radical oxygen species restored clonogenic capacity. Surprisingly, GPx2-suppressed cells also lacked differentiation potential and formed slow-growing undifferentiated tumors. GPx2 overexpression stimulated multilineage differentiation, proliferation, and tumor growth without reducing the tumor-initiating capacity. Finally, GPx2 expression was inversely correlated with H2O2-stress signatures in human colon tumor cohorts, but positively correlated with differentiation and proliferation. Moreover, high GPx2 expression was associated with early tumor recurrence, particularly in the recently identified aggressive subtype of human colon cancer. We conclude that H2O2 neutralization by GPx2 is essential for maintaining clonogenic and metastatic capacity, but also for the generation of differentiated proliferating tumor mass. The results reveal an unexpected redox-controlled link between tumor mass formation and metastatic capacity. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261240     DOI: 10.1158/0008-5472.CAN-14-1645

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

Review 1.  Selenoproteins in colon cancer.

Authors:  Kristin M Peters; Bradley A Carlson; Vadim N Gladyshev; Petra A Tsuji
Journal:  Free Radic Biol Med       Date:  2018-05-22       Impact factor: 7.376

Review 2.  Roles for selenium and selenoprotein P in the development, progression, and prevention of intestinal disease.

Authors:  Sarah P Short; Jennifer M Pilat; Christopher S Williams
Journal:  Free Radic Biol Med       Date:  2018-05-17       Impact factor: 7.376

3.  Selenoprotein H is an essential regulator of redox homeostasis that cooperates with p53 in development and tumorigenesis.

Authors:  Andrew G Cox; Allison Tsomides; Andrew J Kim; Diane Saunders; Katie L Hwang; Kimberley J Evason; Jerry Heidel; Kristin K Brown; Min Yuan; Evan C Lien; Byung Cheon Lee; Sahar Nissim; Bryan Dickinson; Sagar Chhangawala; Christopher J Chang; John M Asara; Yariv Houvras; Vadim N Gladyshev; Wolfram Goessling
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-01       Impact factor: 11.205

Review 4.  Selenium and selenoproteins in prostanoid metabolism and immunity.

Authors:  Fenghua Qian; Sougat Misra; K Sandeep Prabhu
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-01-30       Impact factor: 8.250

Review 5.  The beginning of GPX2 and 30 years later.

Authors:  R Steven Esworthy; James H Doroshow; Fong-Fong Chu
Journal:  Free Radic Biol Med       Date:  2022-07-05       Impact factor: 8.101

6.  Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer.

Authors:  Winston R Becker; Stephanie A Nevins; Derek C Chen; Roxanne Chiu; Aaron M Horning; Tuhin K Guha; Rozelle Laquindanum; Meredith Mills; Hassan Chaib; Uri Ladabaum; Teri Longacre; Jeanne Shen; Edward D Esplin; Anshul Kundaje; James M Ford; Christina Curtis; Michael P Snyder; William J Greenleaf
Journal:  Nat Genet       Date:  2022-06-20       Impact factor: 41.307

7.  Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion.

Authors:  T T Vellinga; S den Uil; I H B Rinkes; D Marvin; B Ponsioen; A Alvarez-Varela; S Fatrai; C Scheele; D A Zwijnenburg; H Snippert; L Vermeulen; J P Medema; H B Stockmann; J Koster; R J A Fijneman; J de Rooij; O Kranenburg
Journal:  Oncogene       Date:  2016-03-21       Impact factor: 9.867

Review 8.  Selenoproteins in Tumorigenesis and Cancer Progression.

Authors:  Sarah P Short; Christopher S Williams
Journal:  Adv Cancer Res       Date:  2017       Impact factor: 6.242

Review 9.  Selenoproteins and Metastasis.

Authors:  Michael P Marciel; Peter R Hoffmann
Journal:  Adv Cancer Res       Date:  2017-09-01       Impact factor: 6.242

10.  Antioxidants Promote Intestinal Tumor Progression in Mice.

Authors:  Zhiyuan V Zou; Kristell Le Gal; Ahmed E El Zowalaty; Lara E Pehlivanoglu; Viktor Garellick; Nadia Gul; Mohamed X Ibrahim; Per-Olof Bergh; Marcus Henricsson; Clotilde Wiel; Levent M Akyürek; Martin O Bergo; Volkan I Sayin; Per Lindahl
Journal:  Antioxidants (Basel)       Date:  2021-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.